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Intraperitoneal administration of the cytokine interleukin-1b (IL-
1b) induces brain-mediated sickness symptoms that can be
blocked by subdiaphragmatic vagotomy. Intraperitoneal IL-1b
also induces expression of the activation marker c-fos in vagal
primary afferent neurons, suggesting that IL-1b is a key com-
ponent of vagally mediated immune-to-brain communication.
The cellular sources of IL-1b activating the vagus are unknown,
but may reside in either blood or in the vagus nerve itself. We
assayed IL-1b protein after intraperitoneal endotoxin [lipopoly-
saccharide (LPS)] injection in abdominal vagus nerve, using
both an ELISA and immunohistochemistry, and in blood plasma
using ELISA. IL-1b levels in abdominal vagus nerve increased
by 45 min after LPS administration and were robust by 60 min.
Plasma IL-1b levels increased by 60 min, whereas little IL-1b
was detected in cervical vagus or sciatic nerve. IL-1b-
immunoreactivity (IR) was expressed in dendritic cells and mac-
rophages within connective tissues associated with the abdom-
inal vagus by 45 min after intraperitoneal LPS injection. By 60
min, some immune cells located within the nerve and vagal
paraganglia also expressed IL-1b-IR. Thus, intraperitoneal LPS
induced IL-1b protein within the vagus in a time-frame consis-
tent with signaling of immune activation. These results suggest
a novel mechanism by which IL-1b may serve as a molecular
link between the immune system and vagus nerve, and thus
the CNS.
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Macrophages, dendritic cells, and other immune cells detect
pathogens such as bacteria or viruses and respond by releasing
proinflammatory mediators, such as the cytokine interleukin-1b
(IL-1b). IL-1b acts both to coordinate the peripheral immune
response and to signal the CNS (Dunn, 1993; Maier et al., 1993).
Such pathogen-induced IL-1b release activates the CNS to or-
chestrate a cascade of endocrine, autonomic, and behavioral
processes collectively termed the acute phase response. This
response functions broadly to render physiological conditions of
the host inhospitable to the pathogen. The precise mechanisms by
which IL-1b signals the CNS are unknown, but possibilities
include direct detection of immune mediators by barrier cells of
the brain (e.g., circumventricular organs and endothelial cells)
(Van Dam et al., 1992; Saper and Breder, 1994; Ericsson et al.,
1997) or by activation of primary afferent neurons of the vagus
nerve (Watkins et al., 1995b).
Subdiaphragmatic vagotomy inhibits a variety of acute phase
responses resulting from intraperitoneal administration of either
IL-1b or lipopolysaccharide (LPS; bacterial endotoxin, which
induces the expression of IL-1b) (Watkins et al., 1994, 1995a;
Bret-Dibat et al., 1995; Gaykema et al., 1995; Hansen and
Krueger, 1997). In addition, the neuronal activation marker c-fos
is expressed in primary afferent neurons of the vagus after intra-
peritoneal administration of either LPS (Gaykema et al., 1998) or
IL-1b (Goehler et al., 1998). Furthermore, sensory structures
associated with the abdominal vagus (vagal paraganglia) express
binding sites for IL-1 ligands (Goehler et al., 1997). These lines of
evidence support the idea that vagal afferents are in fact activated
by immune-related stimuli, notably IL-1b, and relay this infor-
mation to the brain.
Vagal signaling of immune activation must occur fairly rapidly,
because the induction of centrally mediated acute phase re-
sponses such as fever and hyperalgesia occurs within 90 min
(Watkins et al., 1994, 1995a) and the vagal afferent neurotrans-
mitter glutamate (Schaffar et al., 1997) is released in vagal affer-
ent terminal fields within 60 min of intraperitoneal LPS admin-
istration (Mascarucci et al., 1998). If IL-1b is a constituent of a
vagal signaling pathway, it must be induced within this time
frame, in either blood or perivagal immune cells. Accordingly, we
determined the time course of IL-1b protein expression in plasma
and vagus nerve after intraperitoneal LPS administration. To
determine whether LPS induction of IL-1b is specific to the
abdominal vagus rather than a general feature of peripheral
nerves, we compared IL-1b expression in the abdominal vagus
with that in the cervical vagus and sciatic nerves. IL-1b protein
levels were assessed across tissues and time points using an
ELISA. The cell types (e.g., perivagal immune cells) expressing
IL-1b were determined using immunohistochemistry.
MATERIALS AND METHODS
Quantitative assessment of IL-1b with ELISA
Subjects and tissue collection. Adult male Sprague Dawley viral-free rats
(Harlan Sprague Dawley, Indianapolis, IN; 350–400 gm) were used. The
subjects were maintained on a 12 hr light /dark cycle (lights on 7:00
A.M.-7:00 P.M.) with standard laboratory chow and water available ad
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libitum. Temperature in the colony room was maintained at 23°C. All
procedures were in accordance with protocols approved by the Univer-
sity of Colorado Institutional Animal Care and Use Committee.
Rats were injected intraperitoneally with LPS (0111:B4; 100 mg/kg;
Sigma, St. Louis, MO; lot L4391). At either 30, 45, or 60 min after
injection, the animals (n 5 8 per group) were anesthetized with sodium
pentobarbital (60 mg/kg, i.p.), the thoracic cavity was opened, and a
sterile sample of cardiac blood was collected endotoxin-free in heparin-
ized vials containing 17.55 mg EDTA (Becton Dickinson, Franklin
Lakes, NJ) and immediately placed on ice until plasma could be col-
lected. The animals were then quickly perfused transcardially with sa-
line. The ventral abdominal vagus nerve including the hepatic branch, a
1–1.5 cm section of the cervical vagus just distal to the carotid bifurca-
tion, and a 2 cm section of the proximal sciatic nerve distal to the pelvis
and proximal to the knee, were dissected out and immediately frozen on
dry ice. Nerves and plasma were collected from additional rats in an
identical manner 30 (n 5 4) or 60 min (n 5 5) after equivolume vehicle
(pyrogen-free physiological saline, 1 ml/kg). All nerve samples were
stored at 270°C before sonication. Blood samples were kept on ice and
centrifuged at the end of collection at 4°C. Plasma was stored at 220°C
until ELISA.
Tissue processing. Each nerve sample was added to 0.25–0.5 ml of
Iscove’s culture medium containing 5% fetal calf serum and a cocktail
enzyme inhibitor (in mM: 100 amino-n-caproic acid, 10 EDTA, 5 benza-
midine HCl, and 0.2 phenylmethyl sulfonyl fluoride). Total protein was
mechanically dissociated from tissues using an ultrasonic cell disrupter
(Heat Systems, Farmingdale, NY; model MS-50). Sonication consisted of
10 sec of cell disruption at the setting 10. Sonicated samples were
centrifuged at 10,000 3 g, at 4°C, for 10 min. Supernatants were removed
and stored at 4°C until assayed.
Bradford protein assays. Bradford protein assays were performed to
determine total protein concentrations in nerve sonication samples. Total
protein levels were measured using a version of the Coomassie blue
protein assay adapted from Bradford (1976), as previously described
(Nguyen et al., 1998). All data were expressed in terms of micrograms of
protein per 100 ml.
ELISA. The assays were performed using a commercially available rat
IL-1b ELISA kit (R & D systems, Minneapolis MN), as previously
described (Nguyen et al., 1998). This ELISA kit utilizes a rabbit anti-rat
IL-1b polyclonal antibody (Ab) that can recognize both recombinant (r)
as well as natural rat IL-1b. The manufacturer did not observe significant
cross-reactivity of this Ab to rHuman IL-1 receptor type I, IL-1 receptor
type II, IL-1ra, rRat IL-1a, IL-2, IL-4, interferon-g, tumor necrosis
factor-a, rMouse IL-1a, and IL-1ra. The recovery rate of IL-1b with this
assay is between 50 and 70% (our unpublished observations). The results
were expressed as picograms of IL-1b per 100 mg of total protein.
Data analysis. The data were analyzed using ANOVA, followed by post
hoc t tests (Bonferroni-Dunn) for differences between the groups.
Nerve-associated IL-1b immunoreactivity
Subjects and tissue collection. Animals (as above), were injected with 100
mg/kg LPS. Either 30 (n 5 8), 45 (n 5 10), or 60 (n 5 10) min after
injection they were anesthetized and perfused transcardially with saline,
as above. Additional groups of vehicle-treated animals were perfused
either 30 or 60 min after injection. The nerve tissues were dissected in an
identical manner as for the ELISA, as above, and immersion-fixed in 4%
paraformaldehyde/0.1 M phosphate buffer (PB), pH 7.4, for 3–5 hr. They
were cryoprotected overnight in 22% sucrose/PB, sectioned on a cryostat
at 20 mm, and thaw-mounted on electrically charged glass slides (Fisher
Scientific, Houston, TX).
Antisera. The thaw-mounted cryostat sections of nerves were processed
for immunoreactivity (IR) using antisera directed against IL-1b [SILK6:
mouse monoclonal IgG; the epitope is amino acid sequence 123–143 of
the mature rat IL-1b (Schotanus et al., 1995) from Department of
Pharmacology, Vrije Universiteit, Amsterdam, The Netherlands]. In
addition, consecutive sections were processed for the following markers,
to aid in identification of the cells expressing IL-b-IR: tyrosine hydrox-
ylase (TH; Incstar, Stillwater, MN), MHC class II antigen (using OX-6,
mouse monoclonal antibody; Biosource International, Camarillo, CA)
and a macrophage marker (ED-1, mouse monoclonal IgG; Biosource
International). TH is a marker for glomus cells in paraganglia (Berthoud
et al., 1995) and was used solely to confirm the relationship of IL-1b-IR
positive cells with the vagus nerve and paraganglia. TH staining is not
shown. According to the manufacturer (Biosource International), OX-6
labels the class II monomorphic antigen rat /mouse RT1B in dendritic
cells and some macrophages, whereas ED-1 recognizes a 90–100 kDa
antigen present in lysosomal membranes of macrophages and some
dendritic cells.
Single-label immunohistochemistry. Sections were washed in PBS and
immersed in PBS containing 0.3% hydrogen peroxide and 0.1% sodium
azide for 30 min to suppress endogenous peroxidase. Then the slides
were rinsed and incubated in 10% normal goat serum (NGS) in PBS
containing 0.5% Triton X-100 (PBS-T) for 1 hr. With intermittent washes
in PBS, the sections were sequentially incubated in avidin and biotin
(Vector AB blocking kit, both diluted 1:10 in PBS-T, each 1 hr; Vector
Laboratories, Burlingame, CA) to prevent staining of endogenous biotin.
Then the sections were incubated in primary mouse monoclonal anti-
rat /human IL-1b (SILK6, 1:100), mouse monoclonal OX-6 (1:100),
biotinylated mouse monoclonal ED-1 (1:300), or mouse monoclonal
anti-TH (1:1000) overnight at room temperature (RT). The next day the
slides were washed and incubated in secondary biotinylated goat anti-
mouse IgG antibody (1:100; Jackson ImmunoResearch, West Grove, PA)
overnight at RT, except those sections incubated in biotinylated ED-1.
All antibodies were diluted in PBS-T containing 0.1% sodium azide and
10% NGS. Finally, sections were incubated in avidin–biotin complex
(Vector Elite kit, 1:100 in PBS-T, 2 hr; Vector Laboratories) and rinsed
in Tris HCl, pH 7.6. Peroxidase staining was performed using 3,39-
diaminobenzidine (Sigma) as a chromogen dissolved in Tris HCl (50
mg/100 ml) using glucose oxidase (Sigma; type V-S, 0.02%) and b-D-
glucose (0.1%) to generate hydrogen peroxide (Shu et al., 1988). One
series of sections was processed as above except that the primary anti-
body was omitted from the incubation buffer (omission controls). The
slides were dried overnight, counterstained with cresyl violet, and cover-
slipped before viewing with an Olympus Vanox II bright-field micro-
scope. Images were collected with a COHU CCD camera coupled to an
Apple PowerMac 7200 equipped with NIH Image software (version 1.60)
and stored on a Zip cartridge. The obtained micrographs were exported
to and labeled using Adobe Photoshop. Except for small adjustments of
brightness and contrast, the images were not altered.
Double-label immunofluorescence. Sections were washed in PBS and
incubated in 10% NGS in PBS-T for 1 hr. The sections were then
incubated in a mixture of rabbit polyclonal antiserum against IL-1b
(1:100; Endogen, Woburn, MA) and either mouse monoclonal anti-
mouse monoclonal OX-6 (1:100) or mouse monoclonal ED-1 (1:200)
overnight at RT. The antisera were diluted in PBS-T containing 0.1%
sodium azide and 10% NGS. The next day sections were rinsed and
incubated in a mixture of FITC-conjugated goat anti-mouse IgG (1:100;
Jackson ImmunoResearch) and Texas Red-conjugated goat anti-rabbit
IgG (1:100; Jackson ImmunoResearch) overnight at RT. The slides were
then rinsed in several changes of PBS, air-dried, and coverslipped in
Vectashield mounting medium (Vector Laboratories). Adjacent series of
sections were subjected to the same protocol with the omission of one of
the two primary antisera to verify the absence of cross-reactivity. An-
other series of sections were incubated in the same mixture of primary
antisera, diluted in PBS-T and 10% normal donkey serum, and then
immersed in a different mixture of secondary antisera (purified for
minimal cross-reactivity), and with the fluorescent tags reversed: Texas
Red-conjugated donkey anti-mouse IgG, Fab2 fragment (1:100; Jackson
ImmunoResearch), and FITC-conjugated donkey anti-rabbit IgG (1:100;
Jackson ImmunoResearch). The sections were examined in a Nikon
epifluorescence microscope equipped with filters to excite either FITC or
Texas Red, or both.
RESULTS
ELISA analysis
IL-1b protein content of the abdominal vagus nerve increased
over time after intraperitoneal LPS (F(1,23) 5 13.73; p , 0.001)
(Fig. 1A) IL-1b levels were very low (mean 5 0.13 pg/100 mg
protein) at 30 min, but were elevated by 45 min (mean 5 3.03
pg/100 mg protein; p , 0.05). IL-1b levels were robust by 60 min
(mean 5 12.69 pg/100 mg protein; p , 0.0001). In the abdominal
vagus nerves of saline-treated animals, IL-1b levels remained
very low (mean 5 0.08 pg/100 mg protein) at both times tested
(Fig. 1A).
IL-1b levels in plasma increased over time after intraperitoneal
LPS (F(1,31) 5 5.9; p , 0.02) as shown in Figure 1B. IL-1b levels
in plasma (Fig. 1B) remained low but detectable in saline-
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(mean 5 3.7 pg/ml), and LPS-treated animals (means 5 1.5–3.8
pg/ml) until 60 min after LPS injection, at which time plasma
IL-1b content was significantly elevated (mean 5 18.66 pg/ml)
compared with saline controls ( p , 0.0002).
In contrast, cervical vagus nerve and sciatic nerve IL-1b levels
were low or undetectable in both saline- and LPS-treated animals
(Fig. 1A), and thus there were no significant effects of LPS
treatment over time (cervical vagus: F(1,23) 5 0.53, NS; sciatic
nerve: F(1,23) 5 1.3, NS).
Patterns of immune marker immunoreactivity in nerves
Histological differences between the tissues
The ventral abdominal vagus, and especially the hepatic branch,
is characterized by abundant connective tissue, through which
run several small blood vessels and lymph ducts (L. Goehler,
unpublished observations) (Prechtl and Powley, 1987). This con-
nective tissue also contains large aggregates of lymphoid/
myeloid-like cells of varying morphology [nerve-associated lym-
phoid/myeloid cells (NALC)]. In contrast, connective tissue
associated with the cervical vagus is somewhat more limited, and
around the sciatic nerve it is restricted to a thin layer around the
nerve sheath.
Expression of IL-1b immunoreactivity
The results from the immunohistochemical studies mirror those
from the ELISA analysis. IL-1b-IR was not observed in saline-
treated rats at any time point. Whereas IL-1b-IR was induced in
a time-dependent manner in the abdominal vagus, very little
IL-1b-IR was induced in cells associated with either the cervical
region of the vagus or the sciatic nerve. A summary of immuno-
histochemical observations is shown in Table 1.
IL-1b-IR became evident in cells throughout the abdominal
vagus, including the hepatic branch, by 45 min after LPS injec-
tion. Cells expressing IL-1b at this time point were scattered
throughout the connective tissue, but appeared more numerous
along the connective tissue edges (Fig. 2A) and within the NALC.
The level of expression of IL-1b-IR was somewhat variable at this
time point; some animals expressed limited IL-1b-IR, whereas
others exhibited robust induction of IL-1b.
By 60 min after LPS injection, many more cells expressed
IL-1b-IR, and the intensity of staining was much greater (Fig.
2B–F). Cells expressing IL-1b-IR appeared to consist primarily
of cells of the dendritic or macrophage phenotype. Cells with
similar characteristics to those expressing MHC class II-IR (Fig.
2B–D, and see below) expressed IL-1b-IR within the connective
tissue surrounding the nerve, as well as within the perineurium.
Other cells expressing IL-1b-IR included small cells with a dis-
tribution, size, and morphology consistent with macrophages
(Fig. 2E,F, and see below, ED-1-IR). Many darkly stained cells
could be seen among the NALC (Fig. 2E,F). At this time point,
a few cells expressing IL-1b-IR extended within the nerve fibers
(Fig. 2F), and some small cells with thin processes were seen
within many paraganglia (Fig. 3E). The dendritiform processes of
these cells appeared similar to MHC-II-IR also seen in paragan-
glia (Fig. 3D, and see below). Other IL-1b-IR appeared to enve-
lope the unlabeled type I (glomus cells), and thus may represent
type 2 cells (described by Morgan et al., 1976). Variability was
minimal, as all LPS-treated animals expressed robust IL-1b-IR.
Expression of MHC class II-IR (OX-6)
MHC class II-IR occurred in all three (abdominal vagus, cervical
vagus, and sciatic) nerves in saline-treated animals, as well in
those treated with LPS (Fig. 3A–C). MHC class II-IR was par-
ticularly abundant in the abdominal vagus, where cells formed a
plexus extending along and between the vagus nerve fibers. They
Figure 1. Interleukin-1b content as assessed using ELISA in abdominal
vagus, cervical vagus, and proximal sciatic nerve tissues ( A) and blood
plasma (B) 30, 45, and 60 min after intraperitoneal injection of 100 mg/kg
LPS or saline. Only the abdominal vagus shows the induction of IL-1b as
early as 45 min. IL-1b content in plasma is significantly elevated by 60
min. *p , 0.05; **p , 0.0002.
Table 1. Summary of immunohistochemical observations of IL-1b,
OX-6, and Ed-1 immunoreactivity in nerves after intraperitoneal LPS
treatment
Minutes
30 45 60
Abdominal vagus
IL-1 – 11 111
OX-6 111 111 1111
ED-1 1 11 111
Cervical vagus
IL-1 – – –
OX-6 1 1 1
ED-1 1 1 11
Sciatic
IL-1 – – –
OX-6 1 1 1
ED-1 1 1 11
–, Not observed; 1, present; 11, present in moderate amounts; 111, present in
high amounts; 1111, present in very high amounts.
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were dense within the connective tissue, as well as the nerve trunk,
forming the appearance of a network. They occurred in the NALC
as well, where they extended processes around and between the
other cells. Many MHC class II-IR cells were found along and
within the perineurium. Some MHC class II-IR cells extended
across the surface of the vagal paraganglia, where their processes
penetrated between the glomus cells (Fig. 3D). The cells express-
ing MHC class II-IR were comparatively large (10–20 mm) den-
dritiform, and possessed highly variable cell bodies with irregular
shapes (Figs. 3, 4A). Some of these cells were nearly round, with
one or two prominent dendrites, whereas others were elongate or
fusiform. All cells showed strong cytoplasmic expression of MHC
class II-IR. These characteristics suggest that most of these cells
were dendritic cells (Steinman, 1991; Banchereau and Steinman,
1998). MHC class II-IR cells displayed a similar pattern in the
cervical vagus nerve and sciatic nerve, where their distributions
were much more sparse (Fig. 3B,C), even in cervical vagus nerve
samples that contained connective tissue.
Expression of ED-1-IR
ED-1-IR occurred in the sciatic, cervical vagus, and abdominal
vagus nerves at low levels in saline-treated animals and increased
expression was induced by 60 min after LPS injection. However,
ED-1-positive cells were far more numerous in the abundant
connective tissue of the abdominal vagus. These cells were small
(5–10 mm), with a slightly irregular shape (Fig. 3F). They were
located along the connective tissue edges, where they formed
small and large aggregates. ED-1-positive cells were also distrib-
uted among the NALC (Fig. 3F) where they appeared to be major
constituents. Some ED-1-IR occurred along the nerve peri-
neurium, especially at 45 and 60 min after LPS injection.
Double-label immunofluorescence
In sections of vagus nerve incubated with antisera against IL-1b
and either MHC class II or ED-1, double-labeled cells were
observed (Fig. 4). Cells double positive for IL-1b and MHC class
II were large (.10 mm) and varied morphologically. Some cells
were nearly round, but with a distinctly irregularly shaped nu-
cleus (Fig. 4A,A9,B,B9), whereas others were spindle-shaped with
a dendritic appearance (Fig. 4B,B9). Cells double positive for
IL-1b and ED-1 occurred in clumps of smaller cells (6 mm
diameter) primarily in the connective tissue or NALC (Fig.
4C,C9).
Figure 2. LPS-induced IL-1b-IR in tis-
sue associated with the abdominal vagus
nerve. A, Cells in perivagal NALC ex-
pressing IL-1b-IR (dark cytoplasmic
staining indicated with arrows) 45 min
after intraperitoneal LPS administra-
tion. B–D, IL-1b-IR dendritiform cells
in connective tissue adjacent to the ab-
dominal vagus nerve 60 min after LPS.
B shows a high magnification of an IL-
1b-IR dendritiform cell. E, F, Darkly
stained IL-1b-positive cells in perivagal
NALC (E, F, arrow), most of which are
round in shape. Some dendritiform IL-
1b-IR cells are present between nerve
fibers at edge of vagus nerve (F, arrow-
heads). Scale bars: A, 25 mm; B, 10 mm;
C, 50 mm; D, 25 mm; E, 50 mm; F, 50 mm.
NALC, Nerve-associated lymphoid/my-
eloid cells; VN, vagus nerve.
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DISCUSSION
The results of this study demonstrate that IL-1b protein is in-
duced in the abdominal vagus nerve within 1 hr after intraperi-
toneal LPS administration, as assessed by ELISA and immuno-
histochemistry. The cells expressing IL-1b immunoreactivity are
primarily dendritic-type cells that are located along the nerve
perineurium, connective tissue, and NALC, and in macrophage-
like cells located in clusters also within the associated connective
tissue and NALC. In addition, IL-1b immunoreactivity is also
induced in cells located between vagal nerve fibers and in para-
ganglia. These observations are consistent with the idea that
IL-1b is rapidly expressed by immune cells after detection of
pathogens and that these cells then signal the abdominal vagus by
releasing cytokines such as IL-1b.
Rapid induction of perivagal IL-1b is consonant with findings
from other studies implicating IL-1b as a key mediator in immune
signaling from the peritoneum to the brain (Dunn, 1993; Maier et
al., 1993). Intraperitoneal injection of IL-1b activates vagal affer-
ents (Goehler et al., 1998) and initiates brain-mediated acute
phase responses that can be blocked by either pretreatment with
systemic IL-1 receptor antagonist or subdiaphragmatic vagotomy
(Maier et al., 1993, Schotanus et al., 1993; Watkins et al., 1994).
Glutamate, a likely neurotransmitter for a majority of vagal
afferents (Schaffar et al., 1997), is released in the nucleus of the
solitary tract (the site of termination for vagal primary afferent
nerve fibers) after intraperitoneal injection of either LPS or
IL-1b (Mascarucci et al., 1998). Taken together with our obser-
vation of rapid induction of perivagal IL-1b after LPS treatment,
these findings reinforce the idea that a major pathway for the
actions of IL-1b on the brain is via the abdominal vagus nerve.
Site specificity of IL-1b expression in immune cells
associated with nerves
The abdominal vagus nerve was the only nerve tested in which
IL-1b was induced within 60 min after intraperitoneal LPS
treatment. These observations indicate that rapid expression of
intraperitoneal LPS-induced IL-1b is not a general feature of
peripheral nerves.
Although IL-1b was not detected in either the cervical vagus or
proximal sciatic nerve after intraperitoneal LPS treatment, these
nerves do clearly contain small populations of resident immune
cells, as evidenced by the presence of MHC class II-positive cells
observed between the nerve fibers of both the cervical vagus and
sciatic nerves. ED-1-positive macrophage-like cells were also ob-
Figure 3. A–C, MHC class II-IR den-
dritiform cells (dark reaction product)
within the abdominal vagus nerve (A),
cervical vagus nerve (B), and proximal
sciatic nerve ( C). Note the difference in
density of immunostained cells, which is
highest in the abdominal vagus ( A) and
lowest in the proximal sciatic nerve ( C).
MHC class II-IR is present in both
saline- and LPS-treated rats. D, E, Im-
mune cells in abdominal vagal paragan-
glia constitutively expressing MHC class
II-IR (D) interspersed among vagus
nerve fibers and glomus cells in a para-
ganglion, and those with similar mor-
phology expressing LPS-induced IL-
1b-IR (E) surrounding unlabeled
glomus cells. F, ED-1-IR in cells of
perivagal NALC 60 min after LPS treat-
ment, showing macrophage-like (round
or oval-shaped) morphology. Counter-
staining with cresyl violet provides light
background staining in A–D. Scale bars,
50 mm. NALC, Nerve-associated lym-
phoid/myeloid cells; PG, paraganglion;
VN, vagus nerve.
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served in connective tissue associated with these nerves, the
numbers of which appeared to increase moderately after LPS
treatment. This increase in ED-1 expression may represent mi-
gration of activated macrophages to this tissue or may reflect the
possibility that LPS in the systemic circulation by 60 min after the
intraperitoneal injection (our unpublished observations) was suf-
ficient to activate some of the resident cells. The functions of
these nerve-associated immune cells are unclear, but some pos-
sibilities include initiation of immune responses to injury or
infection (Clatworthy et al., 1995; Banchereau and Steinman,
1998) and/or they may serve trophic or regulatory functions, as
has been suggested for dendritic-type cells in endocrine organs
such as pituitary and gonads (Hoek et al., 1997).
The lack of IL-1b expression in the proximal sciatic and the
cervical vagus after LPS may relate to the fact that both these
nerves consist primarily of axons of nerve fibers that terminate a
distance away and may not normally be exposed to immune
stimuli. In contrast, the subdiaphragmatic vagus is located at the
Figure 4. Colocalization of immunofluoresence for IL-1b (A9–C9), MHC-II (A, B), and ED-1 (C) in connective tissue surrounding the abdominal vagus.
A, B9, Arrows indicate cells showing strong immunofluorescence for both MHC-II ( A, B) and IL-1b (A9, B9). Subcellular localization of the two antigens
is not always overlapping. Single arrowheads indicate strongly MHC class II-positive cells that lack prominent labeling for IL-1b. Double arrowheads (A,
A9) point to cells that show clear IL-1b-IR but have weak or no MHC class II-IR. C, C9, Cells show strong dual labeling for ED-1 (C, arrows) and IL-1b
(C9, arrows). Arrowheads point to weak ED-1-positive cells that lack IL-1b-IR. Scale bars, 25 mm.
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distal end of the nerve, closer to terminal fields of vagal afferents,
and thus in closer proximity to likely sites of immune activation
(e.g., by ingested or translocated pathogens, as well as intraperi-
toneal LPS), than are the other two nerve regions. It is also
possible that immune cells in the cervical region of the vagus
and/or the sciatic nerve failed to express IL-1b because they were
not exposed to LPS. However, intraperitoneal LPS at this dose or
similar doses (Lenczowski et al., 1998; our unpublished observa-
tions) can be measured in the general circulation. The time points
investigated in this experiment were intentionally short, and it is
possible that IL-1b may in fact be induced in other nerves, but
later than in the abdominal region of the vagus nerve.
Source of IL-1b relevant to vagal afferents
In this study we show that intraperitoneal LPS induces significant
IL-1b immunoreactivity in plasma by 60 min. IL-1b in plasma
may therefore signal immune activation to vagal afferents. How-
ever, because IL-1b is induced earlier (by 45 min) in perivagal
immune cells, it seems likely that additional sources of IL-1b
relevant to the vagus are located within the nerve or its associated
tissues and are probably dendritic cells and macrophages. These
observations speak to a continuing controversy regarding the
source of IL-1b and other cytokines that activate acute phase
responses. In some studies, acute phase responses are evident in
the absence of detectable levels of cytokines in the circulation
(Kluger, 1991). Even when endotoxin or cytokines are detected in
plasma, their levels or timing do not always correlate with acute
phase activation after intraperitoneal administration of immune
stimuli (Kluger, 1991). These observations have led to the sug-
gestion that the relevant signals are not in the circulation, but
rather arise in the peritoneum or other discrete tissue sites
(Carlson, 1997). However, levels of IL-1b obtained from perito-
neal lavage also do not correlate with brain-mediated illness
responses (Lenczowski et al., 1998). The results from the present
study offer a potential explanation for these seemingly confusing
observations. Perivagal immune cells respond rapidly to intra-
peritoneal LPS, and they are located near enough to the vagal
afferents and/or paraganglia that IL-1b may not need to enter
either the general circulation or the peritoneal fluid to exert its
effects.
Immune cells in paraganglia
The constitutive presence of MHC class II-IR in cells within the
vagal paraganglia suggest that immune cells are normal residents
of these structures. In addition, IL-1b is induced in immune-like,
nonglomus cells by 60 min after intraperitoneal LPS administra-
tion. Glomus cells, many of which are innervated by vagal affer-
ents (Berthoud et al., 1995), can express binding sites for IL-1
ligands (Goehler et al., 1997). The codistribution of glomus-type
cells potentially expressing binding sites for IL-1 with immune-
type cells capable of producing IL-1b provides a possible pathway
by which immune-derived IL-1b, or other mediators, leads to
vagal activation.
Dendritic cells and macrophages as sentinels for the
nervous system
The presence of numerous dendritic cells in such close associa-
tion with vagal nerve fibers and paraganglia reinforces the idea
that one function of the vagus nerve is to signal immune activa-
tion in internal tissues to the CNS. Steinman (1991) has described
dendritic cells as the “sentinels of the immune system”. Dendritic
cells are typically distinguished by their highly irregular cell
shape, numerous and often extensive processes (dendrites), and
high constitutive and cytoplasmic expression of MHC class II
molecules (Cella et al., 1997; Banchereau and Steinman, 1998).
They are specialized to detect pathogens, thus they express pino-
cytic and phagocytic capability, as well as receptors for a variety
of pathogens (Cella et al., 1997). They are well situated to serve
as immune sentinels because they are distributed throughout the
body (Banchereau and Steinman, 1998). When dendritic cells
detect pathogens, they migrate in lymph to the draining lymph
nodes, where they activate T-cells (Ni and O’Neill, 1997). In fact,
dendritic cells are the only cells capable of activating naive T-cells
(Banchereau and Steinman, 1998). Thus, dendritic cells are crit-
ical for the initiation of primary immune responses. Their prom-
inent location within and around vagal nerve fibers and their
expression of IL-1b after LPS administration suggests that they
may serve as immune sentinels for the nervous system as well.
Macrophages, which also responded to intraperitoneal LPS by
expressing IL-1b are also well suited to act as immune-to-brain
sentinels. In addition to important clearance and primary defense
functions (e.g., phagocytosis and release of peroxide and super-
oxide), macrophages help orchestrate primary immune responses
(Goerdt et al., 1996). Macrophages express receptors for
pathogen-associated molecules, such as LPS, and are active
phagocytes, thus able to respond to a wide variety of pathogens
(Goerdt et al., 1996). Their location within vagal nerve connec-
tive tissue and induction of IL-1b after LPS injection suggests
that one function of IL-1b produced by these cells may be to
signal the vagus nerve.
Conclusions
Intraperitoneal LPS induces perivagal immune cells to rapidly
express IL-1b immunoreactivity. These results are consistent
with a model of immune-to-brain communication such that im-
mune activation within the peritoneal cavity stimulates dendritic
cells and macrophages to synthesize and release cytokines such as
IL-1b, which then activate vagal afferents. Vagal afferents then,
via their terminations in the nucleus of the solitary tract, activate
CNS-mediated illness consequences. In this way, immune cells
may signal the brain using a paracrine action to stimulate neural,
in addition to humoral, immune-to-brain communication path-
ways. It may be that this neural pathway is especially important as
a rapid signaling pathway in the early phases of host defense.
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